Hepatocellular Carcinoma: A Review

Dhandhukiya Manavkumar Kanubhai, Saiyed Musaratafrin Sabirali
{"title":"Hepatocellular Carcinoma: A Review","authors":"Dhandhukiya Manavkumar Kanubhai, Saiyed Musaratafrin Sabirali","doi":"10.52711/2231-5659.2023.00030","DOIUrl":null,"url":null,"abstract":"Hepatocellular Carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. Several risk factors responsible for development of HCC are liver and biliary Cirrhosis, Alcohol consumption, Hepatitis B and C infection, exposure to carcinogenic substance like Aflatoxin and Arsenic, comorbid condition like Obesity and Diabetes etc. In this review we discus about risk factors, screening methods and stages of HCC. Multiple treatment availability such as Radiation therapy, Chemotherapy and Surgical procedures along with newer modalities like Targeted Drug Delivery System, use of nano technology, newer Immunomodulators and Radiofrequency Ablation. Continued improvement in both surgical and nonsurgical approaches has demonstrated significant benefits in overall survival.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"405 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Research in Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/2231-5659.2023.00030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatocellular Carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. Several risk factors responsible for development of HCC are liver and biliary Cirrhosis, Alcohol consumption, Hepatitis B and C infection, exposure to carcinogenic substance like Aflatoxin and Arsenic, comorbid condition like Obesity and Diabetes etc. In this review we discus about risk factors, screening methods and stages of HCC. Multiple treatment availability such as Radiation therapy, Chemotherapy and Surgical procedures along with newer modalities like Targeted Drug Delivery System, use of nano technology, newer Immunomodulators and Radiofrequency Ablation. Continued improvement in both surgical and nonsurgical approaches has demonstrated significant benefits in overall survival.
肝细胞癌:综述
肝细胞癌(HCC)是最常见的原发性肝脏恶性肿瘤,也是全球癌症相关死亡的主要原因。导致HCC发生的几个危险因素是肝脏和胆汁性肝硬化、饮酒、乙型和丙型肝炎感染、接触黄曲霉毒素和砷等致癌物质、肥胖和糖尿病等合并症。本文就肝癌的危险因素、筛查方法和分期进行综述。多种治疗方法的可用性,如放射治疗,化疗和外科手术,以及新的模式,如靶向药物输送系统,使用纳米技术,新的免疫调节剂和射频消融术。手术和非手术方法的持续改善已证明对总生存率有显著的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信